Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,174

Document Document Title
WO/2021/026479A9
The present disclosure provides a compound of the formula Het1-L1-Ar1-L2-G1, or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof, that are useful for treating a variety of conditions. In such compounds...  
WO/2021/062555A1
Topical formulations comprising one or more cannabinoids, one or more terpenes, and one or more flavonoids; and methods and uses thereof for the treatment of an integumentary wound, wherein the one or more cannabinoids comprise tetrahydr...  
WO/2021/064724A1
The present invention relates to protopanaxatriol (PPT)-type compounds and compositions comprising thereof useful for controlling insect infestations on plants. The present invention also relates to methods for treating, controlling and/...  
WO/2021/054337A1
The purpose of the present invention is to provide: a composition capable of forming a film that exhibits excellent etching resistance, heat resistance and embedding properties; a resist underlayer film; a method for forming a resist und...  
WO/2021/048657A1
Systems and methods for recovering cyclopentadiene and/or isoprene from a mixture comprising C5 hydrocarbons are disclosed. A C5 mixture comprising cyclopentadiene and/or isoprene is flowed into a dimerization unit to form dimers. The di...  
WO/2021/046628A1
A stable medicinal cannabidiol composition for use in oral delivery, the composition comprising synthetic cannabidiol (CBD) having a purity of at least 99.8 %, preferably at least 99.9 %, together with beta-caryophyllene (BCP) which func...  
WO/2021/047036A1
Disclosed are an enhanced system and process for preparing cyclohexene by hydrogenating benzene, and the present invention belongs to the technical field of the preparation of cyclohexene. In the enhanced system, by installing a first mi...  
WO/2021/030401A1
Processes of making [1.1.1]propellane utilize reaction conditions that include reacting 1,1-dibromo-2,2-bis(chloromethyl)cyclopropane with an effective amount of solid magnesium.  
WO/2021/030773A1
The present disclosure relates to extracellular vesicles, e.g., exosomes, comprising an NLRP3 antagonist. In some aspects, the NLRP3 antagonist comprises an antisense oligonucleotide (ASO). Also provided herein are methods for producing ...  
WO/2021/026479A1
The present disclosure provides a compound of the formula Het1-L1-Ar1-L2-G1, or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof, that are useful for treating a variety of conditions. In such compounds...  
WO/2021/022059A1
The subject matter described herein is directed to compounds, synergistic compositions, and methods for repelling arthropods. The compositions comprise acids, esters, aldehydes, or alcohols of pyrethroid-type compounds. The compounds, pa...  
WO/2021/014422A1
The present invention relates to diterpene compounds of general formula (I) capable of contrasting the antibiotic-resistance mediated by the ArnT enzyme, to their use as a medicament, in particular for use as an adjuvant of an antibiotic...  
WO/2021/016464A1
Provided, inter alia, are methods and compositions for treating FTO-mediated cancer.  
WO/2021/012478A1
Provided are a hydrogenation annule [12] aromatic compound and a preparation method therefor. The hydrogenation annule [12] aromatic compound is a stereoisomer of a represented compound or a compound as represented by formula (I), (I)  
WO/2021/012479A1
Provided are a hydrogenated cyclic [8] aromatic hydrocarbon compound and a preparation method therefor. The hydrogenated cyclic [8] aromatic hydrocarbon compound is a compound as represented by formula (I) or a stereoisomer of the compou...  
WO/2021/012323A1
An electron transport material represented by the following formula (I), a preparation method therefor, use thereof in preparing an organic electroluminescent device, an organic electroluminescent device, an electronic display device and...  
WO/2021/011572A1
Compounds and methods are provided for the treatment of pathogenic virus infections. Compositions and methods are provided for inhibiting RNA viruses.  
WO/2021/007101A1
The present invention provides conjugates of a first polypeptide and a second polypeptide wherein the link between the first polypeptide and the second polypeptide comprises the following moiety.  
WO/2021/000248A1
Disclosed in the present invention are a method and an apparatus for continuous synthesis of cyclopropane compounds. The method comprises the following steps: the synthesis reaction of a diazomethane precursor is carried out continuously...  
WO/2020/264495A1
Provided herein is a compound of Formula (1-I): or a pharmaceutically acceptable salt thereof, wherein R2a, R2b, R3, R4a, R4b, R5, R6a, R6b, R11a, R11b, R16a, R16b, R19, R18, X, q, r, s, t, u, and n are defined herein. Also provided here...  
WO/2020/256546A1
The invention disclosed herein relates to compounds, combinations, kits, and methods using same, for use in bioorthogonal release reactions. In particular, the compounds, combinations and kits of the invention can be used to achieve fast...  
WO/2020/252661A1
A method for the continuous synthesis of propellane compounds, comprising the following steps: using 1,1-dibromo-2,2-chloromethyl cyclopropane or a derivative thereof as a raw material, preparing propellane compounds by means of continuo...  
WO/2020/251346A1
The present invention describes a naturally occurring chemical compound, specifically guayalins A, B, C and D used in medicine having null cytotoxicity and genotoxicity on healthy lymphocyte cells. Said active compounds interfere with th...  
WO/2020/120794A3
The present invention relates to a organic light emitting device comprising a cathode, an anode, a light emitting layer, at least one first electron transport layer and at least one second electron transport layer, wherein the light emit...  
WO/2020/247561A1
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof: Formula (I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of ...  
WO/2020/232530A1
There are provided compositions comprising a purified cannabidiol (CBD) or a derivative thereof and an anti-inflammatory botanical extract, and methods of use thereof for the management of pain in a subject.  
WO/2020/234650A1
A composition comprising an active composition made up of at least 5% CBD, at least 2% β-caryophyllene, and at least 2% linalool; wherein said composition comprises a carrier and excipients to increase oral bioavailability for mammalian...  
WO/2020/223811A1
Pharmaceutical formulations are provided that include at least two antibiotically active ingredients: a cannabinoid that is one or more of cannabichromene (CBC), cannabidiol (CBD) and/or cannabigerol (CBG); a sesquiterpene that is one or...  
WO/2020/227097A1
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-func...  
WO/2020/219774A1
Antibody-drug conjugates (ADCs) comprising an anthracycline and an anti-CD117 antibody are provided, as well as compositions and methods of using the same. The compositions and methods provided herein can also be used to prepare a patien...  
WO/2020/216240A1
The present invention belongs to the field of medicine, and specifically discloses a compound of formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and use thereof in the preparation of a me...  
WO/2020/210831A1
Disclosed herein are compounds including pharmaceutically acceptable salts, esters, prodrugs, hydrates and tautomers thereof which modulate the interactions of CD-40-CD40L. The compounds are useful for treating, ameliorating or preventin...  
WO/2020/210823A1
The invention features compounds and pharmaceutical compositions having anti-inflammatory properties. Also provided are methods of using the compounds or compositions of the invention for treating an inflammatory disorder in a subject in...  
WO/2020/189738A1
A method for producing dicyclopentadiene and isoprene, the method including: a separation step for obtaining, from a raw material mixture that contains a normal form and an iso form of a C5 hydrocarbon, a first mixture that contains the ...  
WO/2020/186139A1
A traction fluid comprising a blend of 2,3-dicyclohexyl-2,3-dimethylbutane (HAD) and 2,3-dicyclohexyl-2,3-dimethylbutane (iso-HAD) is found to have a lower viscosity at low temperatures when compared to a traction fluid having only HAD o...  
WO/2020/168274A1
Disclosed herein are methods and compositions for the treatment and prevention of migraine, migraine-like headaches such as post-traumatic headache, and other related headaches by administering to a subject in need thereof a selective ag...  
WO/2020/168177A1
In one aspect, the disclosure relates to biorenewable polyesters and polyester copolymers derived from camphoric acid, methods of making same, and articles comprising same. The disclosed biorenewable polyesters can have a Mn of from abou...  
WO/2020/144098A1
The invention relates to surfactants of the general formula (I), wherein R is hydrogen or a linear or branched alkyl-, alkenyl-, alkylaryl- or alkenylaryl group with 5 to 25 C atoms, n is a number from 1 to 21 and m is a number from 0 to...  
WO/2020/130280A1
The present invention pertains to a method for recovering a selective homogeneous hydrogenation catalyst and a method for reusing the recovered selective homogeneous hydrogenation catalyst. The method for recovering a selective homogeneo...  
WO/2020/130304A1
A synthesis method and a synthesis device for cyclododecene according to the present invention are high in conversion rate of the reactant cyclododecatriene and in selectivity for the required product cyclododecene while exhibiting the e...  
WO/2020/131490A1
The present disclosure provides processes to convert heavy hydrocarbons to light distillates. The present disclosure further provides compositions including light distillates. In an embodiment, a process for upgrading a hydrocarbon feed ...  
WO/2020/130605A1
The present invention relates to a laurolactam preparation method and a synthesis apparatus, and epoxidation and a rearrangement reaction are carried out in the conversion of cyclododecene into cyclododecanone so that the preparation met...  
WO/2020/121171A1
Systems and methods for producing dicyclopentadiene via thermal dimerization of cyclopentadiene. The feed stream comprising cyclopentadiene is flowed through four shell and tube heat exchangers in series. Each of the shell and tube heat ...  
WO/2020/120794A2
The present invention relates to a organic light emitting device comprising a cathode, an anode, a light emitting layer, at least one first electron transport layer and at least one second electron transport layer, wherein the light emit...  
WO/2020/112357A1
Provided herein are compounds of Formula (I), including methods of making the same. The disclosed compounds are succinate dehydrogenase inhibitors and can be useful in, e.g., inhibiting or preventing fungal growth.  
WO/2020/105711A1
This indene composition has an indene content of 80 to 99.5 mass%. With respect to components other than indene, the content ratio of a C9 or C10 hydrocarbon compound having a 5-member or 6-member condensed ring structure is 90 mass% or ...  
WO/2020/094953A1
The invention relates to the use of at least one cyclophane in a plastic scintillator, as an agent for discriminating between neutrons and gamma rays, as a substitute for the fluorophores which are used in plastic scintillators or as a c...  
WO/2020/091968A1
A catalyst comprising a microporous crystalline metallosilicate having a Constraint Index of 12, or 10, or 8, or 6 or less, a binder, a Group 1 alkali metal or a compound thereof and/or a Group 2 alkaline earth metal or a compound thereo...  
WO/2020/091969A1
A catalyst comprising a microporous crystalline aluminosilicate having a Constraint Index less than or equal to 12, a Group 1 alkali metal or a compound thereof and/or a Group 2 alkaline earth metal or a compound thereof, a Group 10 meta...  
WO/2020/086898A1
This invention employs columns and methods to apply external and internal standards and compounds. Analytical standard or compounds are adsorbed to a solid phase extraction media and are stored indefinitely. The standards or compounds re...  

Matches 1 - 50 out of 7,174